Deep Sedation in Catheter Ablation of Atrial Fibrillation
NCT06836999 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1334
Last updated 2025-03-04
Summary
The current practice of anesthesia for atrial fibrillation catheter ablation (CA) procedure is inconsistent, including general anesthesia, deep sedation, and conscious sedation.Due to the nature of deep sedation, it has been continuously gaining its position as one of the crucial components in standard practices of atrial fibrillation ablation during the last decade. Currently, a considerable number of procedures have been done using conscious sedation. Previous studies explored the benefits obtained from the employment of deep sedation in AF ablation procedures, mainly focused on pain reduction and intra-procedural safety. However, the benefits on long-term rhythmic outcomes, peri-procedural safety as well as benefits on procedural parameters and peri-procedural experiences from patients/ablators/lab staff have yet not to be thoroughly studied. We plan to conduct a prospective, multicenter, randomized, controlled trial to evaluate the benefits of deep sedation in catheter ablation of paroxysmal and persistent AF in multiple prospective, i.e., quantified intraprocedural patients / physicians / lab staffs / mapper clinical specialist experiences, and the procedure safety.
Conditions
- Atrial Fibrillation
- Atrial Fibrillation, Paroxysmal or Persistent
- Deep Sedations
- Conscious Sedation
Interventions
- PROCEDURE
-
deep sedation
The deep sedation was inducted using atropine 0.5 mg iv administered 15 min before the procedure to avoid aspiration. In the EP lab, anesthesia preparation is performed, including invasive arterial blood pressure monitoring via puncture of the radial artery or brachial artery. Noninvasive BP monitoring every 5 minutes is also permitted. Subsequently, midazolam 1-2mg or accompanied with propofol 0.3-0.5 mg/kg is administered intravenously at the start of the CA procedure (i.e., femoral vein puncture), and fentanyl 25 µg is administered intravenously. Then, continuous titrated infusion of propofol 0.2-0.5mg/kg/h for anesthesia maintenance throughout the CA procedure. An additional iv fentanyl (25-50 µg) is administrated at the beginning of RF applications. Further boluses or additional drugs are administrated as needed to maintain analgesia during the procedure. The anesthesiologist is responsible for administering anesthesia and administering medication.
- PROCEDURE
-
Conscious sedation
This protocol is aimed at analgesia, with local infiltration of lidocaine for femoral vein puncture followed by intravenous administration of fentanyl (1-2 ug/kg/h). The operator determines the dose of fentanyl and midazolam. A midazolam 1-5 mg bolus is administrated before electrical cardioversion is performed or when the patient is nervous.
Sponsors & Collaborators
-
The First Affiliated Hospital of Dalian Medical University
lead OTHER
Principal Investigators
-
Yunlong Xia, Ph.D · The First Affiliated Hospital of Dalian Medical University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-03-03
- Primary Completion
- 2027-07-31
- Completion
- 2027-12-31
Countries
- China
Study Locations
More Related Trials
-
Effect of Blood Pressure on Cardiovascular Outcomes and Recurrence After Catheter Ablation in Patients With Atrial Fibrillation
NCT06433336 ·Status: COMPLETED
-
Complex Arrhythmia Registry
NCT07024927 ·Status: NOT_YET_RECRUITING
-
Catheter Ablation Versus Antiarrythmic Drugs for Atrial Fibrillation in China
NCT01341353 ·Status: UNKNOWN ·Phase: PHASE4
-
Surgical Ablation for Atrial Fibrillation
NCT04398979 ·Status: COMPLETED
-
Atrial Fibrillation with Heart Failure with Preserved Ejection Fraction: Treatment Strategies-Catheter Ablation Vs. Anti-Atrial Arrhythmia Drugs
NCT06740539 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Rhythm Control - Catheter Ablation With or Without Anti-arrhythmic Drug Control of Maintaining Sinus Rhythm Versus Rate Control With Medical Therapy and/or Atrio-ventricular Junction Ablation and Pacemaker Treatment for Atrial Fibrillation
NCT01420393 ·Status: COMPLETED ·Phase: NA
-
Ablation Strategies for Persistent Atrial Fibrillation Combined With Heart Failure
NCT06438692 ·Status: RECRUITING ·Phase: NA
-
Application Value of Whole-procedure Optimization for Catheter Ablation of Atrial Fibrillation
NCT06145906 ·Status: RECRUITING
-
Atrial Fibrillation Patients Treated With Catheter Ablation
NCT05266144 ·Status: RECRUITING
-
Feasibility of Pulsed Field Ablation Under Mild Conscious Sedation
NCT06014814 ·Status: COMPLETED
-
Comparison of Catheter Plus Marshall Vein Ablation vs. Catheter Ablation Alone in Persistent AF With Heart Failure
NCT06578793 ·Status: RECRUITING ·Phase: NA
-
Cardiac Denervation in Aortic Arch Replacement
NCT06927908 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Driver Ablation of Persistent Atrial Fibrillation With Severe Atrial Fibrosis.
NCT05085912 ·Status: UNKNOWN ·Phase: NA
-
Left Atrium Substrate Based Ablation Plus Circumferential Pulmonary Vein Isolation to Treat Chronic Atrial Fibrillation
NCT01716143 ·Status: UNKNOWN ·Phase: NA
-
CAB Versus Medical Therapy in Patients With AF and HF With Different EF Categories
NCT05364866 ·Status: UNKNOWN
-
Effect of Catheter Ablation on Left Atrial Function in Persistent Atrial Fibrillation
NCT03443232 ·Status: COMPLETED ·Phase: NA
-
Ablation of Consecutive Atrial Tachycardia
NCT05239364 ·Status: RECRUITING ·Phase: NA
-
Cognitive Function in Patients With Persisted Atrial Fibrillation
NCT04508491 ·Status: COMPLETED ·Phase: NA
-
Ablation of Perimitral Flutter Following Catheter Ablation of Atrial Fibrillation: Impact on Outcomes
NCT01173796 ·Status: COMPLETED ·Phase: PHASE3
-
Medical Economical Evaluation of the Ablation by Catheter of the Atrial Tissue in the Treatment of AF
NCT01183091 ·Status: COMPLETED
-
Radiofrequency Ablation Plus Botulinum Toxin Injection Versus Radiofrequency Ablation Only in Patients With Atrial Flutter
NCT02002962 ·Status: UNKNOWN ·Phase: PHASE2
-
Catheter Ablation Therapy for Persistent Atrial Fibrillation
NCT02892162 ·Status: UNKNOWN ·Phase: NA
-
Left Atrial Isolation by Catheter Ablation in Persistent Atrial Fibrillation With Severe Atrial Fibrosis
NCT05173779 ·Status: UNKNOWN ·Phase: NA
-
Acute Cerebrovascular Events in Patients Undergoing Catheter Ablation
NCT05694273 ·Status: NOT_YET_RECRUITING
-
Rotor Modulation Ablation for the Treatment of Persistent Atrial Fibrillation
NCT06539819 ·Status: NOT_YET_RECRUITING ·Phase: NA